Status:

TERMINATED

Development of a Noninvasive Method of Evaluation of Pulmonary Inflammation in the Condensates of Exhaled Air

Lead Sponsor:

University Hospital, Tours

Conditions:

Bronchopulmonary Ignition

Condensate of Exhaled Air

Eligibility:

All Genders

18+ years

Brief Summary

The aim of the study is identify biological parameters reflecting proteolytic activity in the exhaled condenstaes which might be useful to follow up pulmonary inflammation in various conditions includ...

Detailed Description

5 groups of 20 individuals each: group 1 CF, group 2 COPD, group 3 asthma, group 4 tobacco exposure, group 5 control subjects. Collection of exhaled condensates in all subjects and of sputum in subje...

Eligibility Criteria

Inclusion

  • Inclusion criteria
  • Subjects suffering from CF, COPD, asthma and tobacco exposure (groups 1 to 4) and controls (group 5)
  • aged more or equal to 18
  • stable disease
  • able to perform PFTs
  • informed consent signed
  • affiliated to french social insurance
  • Exclusion Criteria:
  • acute exacerbation of the disease during the last 2 weeks
  • IV or oral steroids or antibiotics during the last 2 weeks
  • hospitalization during the last 2 weeks
  • colonization by S aureus methicillin resistant and/or Burkholderia cepacia

Exclusion

    Key Trial Info

    Start Date :

    July 1 2006

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    July 1 2008

    Estimated Enrollment :

    100 Patients enrolled

    Trial Details

    Trial ID

    NCT00356629

    Start Date

    July 1 2006

    End Date

    July 1 2008

    Last Update

    November 14 2008

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Service de Pneumologie et EFR CHRU Tours

    Tours, France, 37044